SEC Form 4 · accession 0001213900-26-102604
KAMADA LTD · KMDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leon Recanati
Director
Period of report
Aug 27, 2026
Accepted (ET)
Sep 23, 2026 · 3:58 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001567529
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3,F1,F4,F2 | $7.41 | Aug 27, 2026 | A | 26,500 | A | — | — | Ordinary Shares | 26,500 | 26,500 | I |
| Employee Stock Option (right to buy)F3,F1,F5,F2 | $5.99 | Aug 27, 2026 | A | 30,000 | A | — | — | Ordinary Shares | 30,000 | 30,000 | I |
| Employee Stock Option (right to buy)F3,F1,F6,F2 | $7.38 | Aug 27, 2026 | A | 30,000 | A | — | — | Ordinary Shares | 30,000 | 30,000 | I |
Explanation of responses
- F1The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
- F2The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.
- F3Held by trustee under the Company's 2011 Share Award Plan.
- F4This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.58. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
- F5This option was previously reported as covering 30,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
- F6This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.